Real	O
-	O
time	O
observation	B:C0302523
of	O
protein	O
aggregates	I:C3850144
in	O
pharmaceutical	O
formulations	O
using	O
liquid	O
cell	I:C0026019
electron	I:C0026019
microscopy	I:C0026019
.	O

Real	O
-	O
time	O
observation	O
of	O
protein	B:C3850144
aggregates	I:C3850144
in	O
pharmaceutical	O
formulations	O
using	O
liquid	O
cell	I:C0026019
electron	I:C0026019
microscopy	I:C0026019
.	O

Real	O
-	O
time	O
observation	O
of	O
protein	O
aggregates	I:C3850144
in	O
pharmaceutical	O
formulations	O
using	O
liquid	B:C0026019
cell	I:C0026019
electron	I:C0026019
microscopy	I:C0026019
.	O

Understanding	O
the	O
properties	O
of	O
protein	O
-	O
based	O
therapeutics	O
is	O
a	O
common	O
goal	O
of	O
biologists	B:C0334861
and	O
physicians	O
.	O

Understanding	O
the	O
properties	O
of	O
protein	O
-	O
based	O
therapeutics	O
is	O
a	O
common	O
goal	O
of	O
biologists	O
and	O
physicians	B:C0031831
.	O

Technical	O
barriers	O
in	O
the	O
direct	O
observation	B:C0302523
of	O
small	O
proteins	I:C0033684
or	O
therapeutic	O
agents	I:C1611640
can	O
limit	O
our	O
knowledge	O
of	O
how	O
they	O
function	O
in	O
solution	O
and	O
in	O
the	O
body	O
.	O

Technical	O
barriers	O
in	O
the	O
direct	O
observation	O
of	O
small	B:C0033684
proteins	I:C0033684
or	O
therapeutic	O
agents	I:C1611640
can	O
limit	O
our	O
knowledge	O
of	O
how	O
they	O
function	O
in	O
solution	O
and	O
in	O
the	O
body	O
.	O

Technical	O
barriers	O
in	O
the	O
direct	O
observation	O
of	O
small	O
proteins	I:C0033684
or	O
therapeutic	B:C1611640
agents	I:C1611640
can	O
limit	O
our	O
knowledge	O
of	O
how	O
they	O
function	O
in	O
solution	O
and	O
in	O
the	O
body	O
.	O

Technical	O
barriers	O
in	O
the	O
direct	O
observation	O
of	O
small	O
proteins	I:C0033684
or	O
therapeutic	O
agents	I:C1611640
can	O
limit	O
our	O
knowledge	O
of	O
how	O
they	O
function	O
in	O
solution	O
and	O
in	O
the	O
body	B:C0242821
.	O

Electron	B:C0026019
microscopy	I:C0026019
(	O
Electron	O
microscopy	I:C0026019
)	O
imaging	O
performed	O
in	O
a	O
liquid	O
environment	O
permits	O
us	O
to	O
peer	O
into	O
the	O
active	O
world	O
of	O
cells	O
and	O
molecules	O
at	O
the	O
nanoscale	O
.	O

Electron	O
microscopy	I:C0026019
(	O
Electron	B:C0026019
microscopy	I:C0026019
)	O
imaging	O
performed	O
in	O
a	O
liquid	O
environment	O
permits	O
us	O
to	O
peer	O
into	O
the	O
active	O
world	O
of	O
cells	O
and	O
molecules	O
at	O
the	O
nanoscale	O
.	O

Electron	O
microscopy	I:C0026019
(	O
Electron	O
microscopy	I:C0026019
)	O
imaging	B:C0011923
performed	O
in	O
a	O
liquid	O
environment	O
permits	O
us	O
to	O
peer	O
into	O
the	O
active	O
world	O
of	O
cells	O
and	O
molecules	O
at	O
the	O
nanoscale	O
.	O

Electron	O
microscopy	I:C0026019
(	O
Electron	O
microscopy	I:C0026019
)	O
imaging	O
performed	O
in	O
a	O
liquid	O
environment	B:C0014406
permits	O
us	O
to	O
peer	O
into	O
the	O
active	O
world	O
of	O
cells	O
and	O
molecules	O
at	O
the	O
nanoscale	O
.	O

Electron	O
microscopy	I:C0026019
(	O
Electron	O
microscopy	I:C0026019
)	O
imaging	O
performed	O
in	O
a	O
liquid	O
environment	O
permits	O
us	O
to	O
peer	O
into	O
the	O
active	O
world	O
of	O
cells	B:C0007634
and	O
molecules	O
at	O
the	O
nanoscale	O
.	O

Here	O
,	O
we	O
employ	O
liquid	B:C0026019
cell	I:C0026019
EM	I:C0026019
to	O
directly	O
visualize	O
a	O
protein	O
-	O
based	O
therapeutic	O
in	O
its	O
native	O
conformation	I:C0033625
and	O
aggregate	O
state	O
in	O
a	O
time	O
-	O
resolved	O
manner	O
.	O

Here	O
,	O
we	O
employ	O
liquid	O
cell	I:C0026019
EM	I:C0026019
to	O
directly	O
visualize	O
a	O
protein	O
-	O
based	O
therapeutic	O
in	O
its	O
native	B:C0033625
conformation	I:C0033625
and	O
aggregate	O
state	O
in	O
a	O
time	O
-	O
resolved	O
manner	O
.	O

In	O
combination	O
with	O
quantitative	B:C0200767
analyses	I:C0200767
,	O
information	O
from	O
this	O
work	O
contributes	O
new	O
molecular	O
insights	O
toward	O
understanding	O
the	O
behaviours	O
of	O
immunotherapies	O
in	O
a	O
solution	O
state	O
that	O
mimics	O
the	O
human	O
body	I:C0242821
.	O

In	O
combination	O
with	O
quantitative	O
analyses	I:C0200767
,	O
information	O
from	O
this	O
work	O
contributes	O
new	O
molecular	O
insights	B:C0233820
toward	O
understanding	O
the	O
behaviours	O
of	O
immunotherapies	O
in	O
a	O
solution	O
state	O
that	O
mimics	O
the	O
human	O
body	I:C0242821
.	O

In	O
combination	O
with	O
quantitative	O
analyses	I:C0200767
,	O
information	O
from	O
this	O
work	O
contributes	O
new	O
molecular	O
insights	O
toward	O
understanding	O
the	O
behaviours	O
of	O
immunotherapies	B:C0021083
in	O
a	O
solution	O
state	O
that	O
mimics	O
the	O
human	O
body	I:C0242821
.	O

In	O
combination	O
with	O
quantitative	O
analyses	I:C0200767
,	O
information	O
from	O
this	O
work	O
contributes	O
new	O
molecular	O
insights	O
toward	O
understanding	O
the	O
behaviours	O
of	O
immunotherapies	O
in	O
a	O
solution	O
state	O
that	O
mimics	O
the	O
human	B:C0242821
body	I:C0242821
.	O

